Cited by 106Medication Adherence and ComplianceAsthma and respiratory diseasesAdrenal Hormones and Disorders

Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children

Open access
Jochmann, Anja, Artusio, Luca, Jamalzadeh, Angela, Nagakumar, Prasad, Delgado-Eckert, Edgar, Saglani, Sejal, Bush, Andrew, Frey, Urs +1 more·2017·European Respiratory Journal

Abstract

International guidelines recommend that severe asthma can only be diagnosed after contributory factors, including adherence, have been addressed. Accurate assessment of adherence is difficult in clinical practice. We hypothesised that electronic monitoring in children would identify nonadherence, thus delineating the small number with true severe asthma.Asthmatic children already prescribed inhaled corticosteroids were prospectively recruited and persistence of adherence assessed using electronic monitoring devices. Spirometry, airway inflammation and asthma control were measured at the start and end of the monitoring period.93 children (62 male; median age 12.4 years) were monitored for a median of 92 days. Median (range) monitored adherence was 74% (21-99%). We identified four groups: 1) good adherence during monitoring with improved control, 24% (likely previous poor adherence); 2) good adherence with poor control, 18% (severe therapy-resistant asthma); 3) poor adherence with good control, 26% (likely overtreated); and 4) poor adherence with poor control, 32%. No clinical parameter prior to monitoring distinguished these groups.Electronic monitoring is a useful tool for identifying children in whom a step up in treatment is indicated. Different approaches are needed in those who are controlled when adherent or who are nonadherent. Electronic monitoring is essential in a paediatric severe asthma clinic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/13993003.00910-2017

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Despite interventions and treatments aimed at addressing modifiable factors and comorbidities, some children with difficult asthma and Asthma plus may not improve because of continued poor adherence with medications or ongoing high exposure to allergens, in which case they should be considered as having refractory difficult asthma or refractory Asthma plus.

    “However, despite interventions and treatments aimed at addressing modifiable factors and comorbidities, some children with DA and Asthma plus may not improve [e.g., because of the continued poor adherence with medications (50, 68), or ongoing high exposure to allergens (69–71)], in which case they should be considered as having refractory DA or refractory Asthma plus (46, 72).”

    From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [50]

  • The limitation of the use of maximum treatment is that there may be different reasons for poor asthma control among patients on maximum treatment, such as wrong diagnosis, non-adherence with medication, or therapy-resistant disease.

    “The limitation of the use of “maximum treatment” is that there may be different reasons for poor asthma control among patients on “maximum treatment,” such as the wrong diagnosis (46), non-adherence with medication (50), or therapy-resistant disease (48).”

    From Epidemiology of Asthma in Children and Adults (2019) · cites this paper as [50]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Santos PdeM, D'Oliveira A Jr, Noblat LdeA, et al. Predictors of adherence to treatment in patients with severe asthma treated at a referral center in Bahia, Brazil. J Bras Pneumol 2008; 34: 995-1002.
  2. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011; 184: 602-615.

Cited by

Sorted by citations

Authors
Jochmann, A., Artusio, L., Jamalzadeh, A., Nagakumar, P., Delgado-Eckert, E., Saglani, S., Bush, A., Frey, U., & Fleming, L. J.
Affiliations
  • University of Basel (CH)
  • Royal Brompton Hospital (GB)
Venue
European Respiratory Journal
Published
2017-12
Volume
50
Issue
6
Pages
1700910
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2777461381
Cited by
104
References
29
Citations by year
2026: 7 · 2025: 4 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 16 · 2020: 21 · 2019: 25 · 2018: 7 · 2017: 1
FWCI
15.42
Type
journal article
Language
en
Open access
Locations
  • European Respiratory Journal (publishedVersion)
  • PubMed (publishedVersion)
  • edoc (University of Basel) (acceptedVersion)
  • Spiral (Imperial College London) (submittedVersion)
  • edoc (University of Basel)
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2SKP3_151971)
  • Asthma UK Innovations (AUK-IG-2014-284)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
electronic medication monitoring, medication adherence, inhaled corticosteroids, severe asthma, childhood asthma, asthma control, airway inflammation, therapy-resistant asthma, overtreatment, treatment escalation
MeSH terms
Administration, Inhalation, Adolescent, Adrenal Cortex Hormones, Asthma, Child, Child, Preschool, Female, United Kingdom, Humans, Male, Prospective Studies, Drug Monitoring, Anti-Asthmatic Agents, Electrical Equipment and Supplies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review